Staples Inc’s proposed takeover of Office Depot Inc has been approved by European regulators after the U.S. office supplies retailer agreed to sell some of the European operations of its smaller rival.
The approval comes two months after the U.S. antitrust regulator filed a complaint to block the $6.3-billion deal on concerns that it would reduce competition for nationwide contracts for office supplies in the United States.
Staples said on Wednesday that it agreed to sell Office Depot’s contract distribution business in Europe and all operations in Sweden.
The companies will also divest Office Depot’s retail, online and catalog operations in Europe.
“The commitments remove the entire overlap between the merging companies in all markets where concerns were raised, thus ensuring that an important alternative will remain available on these highly concentrated markets,” the European Commission said in a statement.
Besides the litigation with the U.S. Federal Trade Commission, the companies are facing heavy scrutiny from the Canadian Competition Bureau.
Staples had said it was willing to continue talks with the FTC to address the regulator’s concerns.
The acquisition has been approved in Australia, New Zealand, China and Europe.
Full content: The New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas